Formerly known as Global Research & Risk Solutions
End-to-end support across the investment life cycle
US-based private market General Partner (GP); AUM: $80+ bn
Requirement
- Expand the private equity portfolio through a cost-effective model
Challenges faced by the client
- Limited bandwidth across departments
- Constrained value creation capabilities
- Availability of data analytics talent
Crisil solution
Investment research and portfolio support
- 20 FTEs research support on target identification, due diligence, incl. financial modeling, portfolio monitoring
- Support across Tech, Healthcare/Life Sciences, Financial Services, Renewables and Consumer sectors
- Provides recommendations to investment committee
- 8 FTEs supporting active portfolio value creation
Data intelligence support
- 2 FTEs to support on data and build analytical insights
- Design pricing strategies and built investor networks
Marketing collaterals support
- Produce sector-focused primers, insights, newsletters
Crisil impact
Benefits to the client
- Optimize onshore bandwidth
- Expand the global portfolio by 2x and AUM by 3x
- Flexible scaling of team to service peak deal cycles
- Operations cost saving of ~50%
Explore Crisil, a company of S&P Global